000			01738 a2200505 4500
005			20250513123258.0
264		0	_c19970828
008			199708s 0 0 eng d
022			_a0950-9232
024	7		_a10.1038/sj.onc.1201213 _2doi
040			_aNLM _beng _cNLM
100	1		_aOh, J W
245	0	0	_aUnmasking by soluble IL-6 receptor of IL-6 effect on metastatic melanoma: growth inhibition and differentiation of B16-F10.9 tumor cells. _h[electronic resource]
260			_bOncogene _cJul 1997
300			_a569-77 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAnimals
650	0	4	_aAntigens, CD _xchemistry
650	0	4	_aCell Differentiation _xdrug effects
650	0	4	_aCell Division _xdrug effects
650	0	4	_aCricetinae
650	0	4	_aCyclin-Dependent Kinase Inhibitor p21
650	0	4	_aCyclins _xdrug effects
650	0	4	_aDNA-Binding Proteins _xdrug effects
650	0	4	_aHumans
650	0	4	_aInterferon Regulatory Factor-1
650	0	4	_aInterleukin-6 _xpharmacology
650	0	4	_aMelanoma _xdrug therapy
650	0	4	_aMice
650	0	4	_aPhosphoproteins _xdrug effects
650	0	4	_aReceptors, Interleukin _xchemistry
650	0	4	_aReceptors, Interleukin-6
650	0	4	_aRecombinant Proteins _xgenetics
650	0	4	_aSTAT1 Transcription Factor
650	0	4	_aSolubility
650	0	4	_aTrans-Activators _xdrug effects
650	0	4	_aTumor Cells, Cultured
700	1		_aKatz, A
700	1		_aHarroch, S
700	1		_aEisenbach, L
700	1		_aRevel, M
700	1		_aChebath, J
773	0		_tOncogene _gvol. 15 _gno. 5 _gp. 569-77
856	4	0	_uhttps://doi.org/10.1038/sj.onc.1201213 _zAvailable from publisher's website
999			_c9227237 _d9227237